Jane Meng is an accomplished professional in the field of toxicology and non-clinical development, currently serving as Vice President of Toxicology at Structure Therapeutics since July 2023. In this role, Jane oversees non-clinical safety evaluations for candidate selection and IND-enabling programs, manages departmental operations, and drives translational toxicity evaluations. Prior experience includes leading the BJ Center and non-clinical research at I-Mab Biopharma, where Jane was instrumental in facilitating the transition of product candidates to clinical development. Additional roles at Covance Shanghai, Pharmaron Beijing, and BeiGene further established Jane's expertise in planning and executing preclinical safety studies and advising on drug development. Jane holds a PhD in Pharmacology from 清华大学 and is a Diplomate of the American Board of Toxicology.
This person is not in any teams
This person is not in any offices